激光间质热疗调控胶质瘤微环境的机制与治疗意义
本文为叙述性综述,综合临床前与临床研究,探讨激光间质热疗(LITT)如何调控胶质瘤微环境。LITT产生三个空间分布不同的热区,促进损伤相关分子模式释放、免疫细胞活化及血脑屏障短暂破坏,可能将免疫「冷」肿瘤转为「热」肿瘤,并增强化疗、免疫及病毒或基因治疗的递送。
要点
- LITT通过三个热区促进DAMP释放、免疫活化及血脑屏障短暂开放。
- LITT可能增强化疗、免疫及病毒或基因治疗的递送效率。
- 需优化治疗时机、患者选择及联合方案以充分发挥LITT生物学效应。
核心结论
- LITT不仅是不可切除胶质瘤的减瘤工具,还可能作为免疫调节与治疗增强平台。
研究设计与样本
- 叙述性综述,覆盖临床前与临床研究,综合LITT对免疫激活、血脑屏障通透性及热动力学的影响。
主要发现
- LITT产生三个空间分布不同的热区,促进DAMP释放、免疫细胞活化及血脑屏障短暂破坏。
- 这些变化可能将免疫「冷」胶质瘤转为「热」肿瘤,并增强化疗、免疫及病毒或基因治疗的递送。
- 血管结构附近的热沉效应等技术局限正通过双光纤系统和先进热建模等创新加以解决。
临床怎么用
- LITT可能招募并动员免疫系统靶向癌细胞、改善现有疗法渗透、降低既往受限药物的有效剂量以减少外周不良反应,并改善外周液体活检潜力。
局限性
- 血管结构附近的热沉效应等技术局限仍存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Glioblastoma (GBM) remains one of the most deadly brain tumors through its invasiveness, rapid growth, its immunosuppressive microenvironment, and limited treatment options. Laser interstitial thermal therapy (LITT) is an MR-guided, minimally invasive ablation technique increasingly used in GBM management. This narrative review examines how LITT modulates the glioma microenvironment and explores its therapeutic implications. We cover both preclinical and clinical studies and synthesize the effects of LITT on immune activation, blood-brain barrier (BBB) permeability, and thermal dynamics in gliomas. LITT generates three spatially distinct thermal zones, promoting damage-associated molecular pattern (DAMP) release, immune cell activation, and transient BBB disruption. These changes may help convert immunologically "cold" gliomas into "hot" tumors and enhance the delivery of chemotherapy, immunotherapy, and viral or gene-based therapies. Technical limitations, such as the heat sink effect near vascular structures, are increasingly addressed through innovations like dual-fiber systems and advanced thermal modeling. LITT is emerging as much more than a cytoreductive tool for unresectable glioma; it may provide a platform for immune modulation and therapeutic enhancement in glioma care. Potential benefits of LITT's interaction with the microenvironment and the BBB include: (1) recruitment and mobilization of the immune system to better target cancerous cells; (2) improved penetration of existing therapies; (3) which enables a lower effective dose for previously barred-drugs, reducing peripheral adverse effects; (4) improved potential for peripheral liquid biopsy. Optimizing treatment timing, patient selection, and combination protocols will be essential to fully harness LITT's biological effects and improve clinical outcomes. Not applicable.
引用
- Vargas LO, Himic V, Otaner F, et al. Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications. J Neurooncol. 2025. PMID: 41307758. doi:10.1007/s11060-025-05305-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。